Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ALW-II-41-27 (Eph receptor tyrosine kinase inhibitor), an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 63.00 | |
2 mg | In stock | $ 98.00 | |
5 mg | In stock | $ 179.00 | |
10 mg | In stock | $ 277.00 | |
25 mg | In stock | $ 459.00 | |
50 mg | In stock | $ 673.00 | |
100 mg | In stock | $ 958.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 253.00 |
Description | ALW-II-41-27 (Eph receptor tyrosine kinase inhibitor), an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy. |
Targets&IC50 | Eph family tyrosine kinase:11 nM |
In vitro | ALW-II-41-27 inhibits Ba/F3 cells (EC50<500 nM) transformed with Tel fusions of Kit, EphA3, Fms, KDR, FLT1, FGR, Src, Bmx, Lyn, and Bcr-Abl. ALW-II-41-27 has cross-reactivity with Bcr-Abl. ALW-II-41-27 inhibits b-Raf, CSF1R, DDR1, DDR2, EphA2, EphA8, EphB1, EphB2, Kit, EphB3, Frk, Lck, EphA5, p38α, p38β, PDGFRβ, PDGFRα, and Raf1. |
Synonyms | Eph receptor tyrosine kinase inhibitor |
Molecular Weight | 607.69 |
Formula | C32H32F3N5O2S |
CAS No. | 1186206-79-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (90.51 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ALW-II-41-27 1186206-79-0 Tyrosine Kinase/Adaptors Ephrin Receptor ALWII4127 Inhibitor inhibit ALW II 41 27 Eph receptor tyrosine kinase inhibitor inhibitor